{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-23-061642","form_type":"8-K","ticker":"ONCO","cik":"0001782107","company_name":"Onconetix, Inc.","filed_at":"2023-08-01T23:59:59+00:00","discovered_at":"2026-05-14T18:03:35.210546+00:00","generated_at":"2026-06-12T18:43:15.449483+00:00","sec_items":["1.01","3.02","7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Blue Water Biotech raises ~$2.7M via warrant exercise inducement; issues new warrants for 4.97M shares","bullets":["Holder exercises existing warrants for 2,486,214 shares at reduced price of $1.09/share; gross proceeds ~$2.7M.","Company issues new warrants to purchase up to 4,972,428 shares at $1.09/share, exercisable for 5 years after stockholder approval.","Proceeds used for working capital and launch activities for commercial portfolio; closing expected August 2, 2023.","H.C. Wainwright acts as placement agent; receives 7.5% cash fee plus warrants.","New warrants and shares unregistered; resale registration statement to be filed within 90 days."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-23-061642","json":"https://secwatch.observer/filing/0001213900-23-061642.json","markdown":"https://secwatch.observer/filing/0001213900-23-061642.md","text":"https://secwatch.observer/filing/0001213900-23-061642.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1782107/000121390023061642/0001213900-23-061642-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1782107/000121390023061642/ea182607-8k_bluewater.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-12T18:43:15.449483+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"2aed2eb74cab10079b9a5eb510e6e0ca1c684813","claim":"Onconetix, Inc. entered into Inducement Letter with a certain holder of existing preferred investment options valued at approximately $2,709,973 (effective 2023-07-31).","evidence_excerpt":"On July 31, 2023, Blue Water Biotech, Inc., a Delaware corporation (the “Company”), entered into a common stock preferred investment options exercise inducement offer letter (the “Inducement Letter”) with a certain holder (the “Holder”) of existing preferred investment options (“PIOs”) to purchase shares of the Company’s common stock","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1782107/000121390023061642/0001213900-23-061642-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"equity purchase"},{"label":"Counterparty","value":"a certain holder of existing preferred investment options"},{"label":"Value","value":"approximately $2,709,973"},{"label":"Effective","value":"2023-07-31"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}